chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chief Complaint Patient presents with ? Fatigue pt states food just does not taste right, he feels like he has no taste, sx started about 2 - 3 weeks ago, was around positive exposures  ED to Hosp-Admission Current  8/27/2021 - present (5 days) Patient is being admitted to medical surgical unit.   Acute hypoxic respiratory failure. Bilateral pneumonia secondary to coronavirus infection. o Patient's COVID-19 virus testing is positive. o Treatment protocol will be implemented. o Steroids are going to be used orally o Empiric antibiotics are initiated.    Chief Complaint Patient presents with ? Shortness of Breath     Patient is an 83 y.o. male presented to Emergency Care Unit for evaluation of fever, fatigue, decreased taste and cough.  Patient does have a reported exposure to coronavirus about 2 weeks ago.  He had been tested in the past and the test was positive.  He denies having nausea, vomiting or diarrhea.       During the initial stages of evaluation in emergency care unit the following test and imaging were ordered.  I have personally reviewed the results: o Hematology panel is generally unremarkable. o Procalcitonin is mildly elevated 2.41 ng/mL. o Troponin is 0.03 ng/mL. o Comprehensive metabolic panel is revealing depleted sodium to 140 mmol/L. o BUN and creatinine are elevated indicative of the acute renal injury. o Patient does have elevated AST and ALT. o Lactate is within normal range. o Microbiology studies reviewed detected corona virus?COVID-19. o Imaging studies confirm bilateral interstitial changes in both lung bases. o EKG is revealing normal sinus rhythm     Review of Systems  Constitutional: Positive for appetite change, fatigue and fever.  HENT: Positive for congestion and sore throat.   Eyes: Negative.  Negative for discharge.  Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Positive for chest pain and palpitations.  Gastrointestinal: Positive for diarrhea.  Endocrine: Negative.   Genitourinary: Negative.  Negative for difficulty urinating.  Musculoskeletal: Positive for arthralgias and myalgias.  Skin: Negative.  Negative for rash.  Allergic/Immunologic: Negative.   Neurological: Positive for dizziness and weakness.  Hematological: Negative.  Negative for adenopathy.  Psychiatric/Behavioral: The patient is nervous/anxious.   All other systems reviewed and are negative.
This spontaneous report as received from a medical assistant refers to a 9 week old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 03-OCT-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # N022015, expiry date: 10-MAR-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37°F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868: Original Case: 1809USA002868; US-009507513-1902USA009324: Original Case: 1902USA009323; US-009507513-1902USA009323: Original Case: 1902USA009323; US-009507513-1902USA009326: Original Case: 1902USA009323.
Information regarding Prevnar was received from a nurse regarding a patient who received a dose on an unspecified date. The reporter noted that Prevnar injection "hurts" more than other vaccines. On an unspecified date, the patient received a dose of Prevnar. The reporter noted that the Prevnar injection "hurts" more than other vaccines. As of 04-Apr-2006, it was unknown if the patient recovered from the event. The reporter was unable to specify the number of patients who experienced this event. Additional reports will be generated when identifying information is provided. No additional information was available at the time of this report.
I received Pfizer first shot and was fine. The incident occurred after the second shot at the same facility. I left the facility after waiting 25 minutes. Someone coughed near me so I decided to leave. My heart was racing but I thought I was nervous about the person coughing. As I was driving home I started to experience a reaction.  There was a tingling feeling in my left hand and numbness in my left fingers. I wiggled my fingers , which seemed to help. However, my heart was still racing. I decided to stop outside a doctor?s office in the Center and take some Benadryl. After a few minutes I felt a little better , and drove 3 minutes to my  own doctor?s office. My heart was still racing and I felt numbness in mouth, similar to shell fish allergy reaction.   I was worried I would experience breathing problems next, but that did not occur. So, I made a visit to the doctor, who examined  me. My blood pressure was elevated. The reaction subsided after one hour from the time the vaccine was administered. I eventually was sent home.
The day after the vaccine  (Wednesday) he felt weak and stayed in bed.  The next day (Thursday), he tried to get up and "his legs wouldn't work".  He couldn't move them.  He didn't have pain but this caused him to fall when trying to get out of bed.  He stayed in bed the rest of Thursday evening.  On Friday, he felt slightly better but dizzy.  Had some strength in his legs and felt strong enough to walk.  Walked away from his bed and fell and hit his head.   He was hospitalized from Friday to Monday.  On Monday he was brought to a rehab facility and had a roommate.  His roommate was an elderly man as well.  As they were talking, the roommate shared the exact same story of getting Moderna after several Pfizer doses, being weak in bed, then not being able to move his legs, then falling from bed.  I don't have the roommates details, and he was discharged from Rehab Hospital on Tuesday 11/15.  I was shocked to hear such a similar story so I thought it was worth reporting. Especially since they both verbalized not being able to move their legs for about 1 day.  He was able to go home.  Patient should be able to go home next week.  Patient has recovered with time.  He now has his strength back but is having some urinary retention issues that he didn't have to this extent before.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  PERIPHERAL NEUROPATHY ACUTE ST ELEVATION MI, UNSPECIFIED 7/7/2023 -- RECURRENCE OF SAME SYMPTOMS
High anion gap metabolic acidosis. Patient developed poor appetite, nausea, and vomiting. She was unable to tolerate oral intake. She presented to the emergency department after two days of vomiting and was found to have high anion gap metabolic acidosis with pH of 7.0 requiring ICU stay. She had no prior hx of diabetes and was noted to be euglycemic. Patient's acidosis resolved after IVF resuscitation.
On 4/12/06 pt called complaining of pain in his left arm (especially0 on the back of the arm and shoulder, Pt states no swelling or redness. Pain started after vaccination and became worse on Sat 4/8/06. Pt was referred to DR and clinic. He also was told to take some Ibuprofen. On 4/12/06 Pt states it was hard to raise his arm.
Chills, very swollen arm, skin on arm hot and bright red. All this cleared up only to leave me with arm pain that has continued to today
Had Pfizer Covid 19 04/24/21, Woke up with pain right side of neck yesterday worse with movements. Right cheek swollen. Ibuprofen 800 mg prescribed Moist heat & ice packs reccomended
Received flu & pneumonia vaccine approx 8:45 am on 10-28-08.  By noon her arm became extremely sore to where she could not lift it.  Rash under the skin & scratchy throat began 10-29-08 in the evening.  Red streaks were 5" by 5" in diameter & even under her armpits.   She began to cx of itching on her ears, nose, head.  Nurse adv. to seek medical attention.  Taking Claritin in afternoon and Benadryl in p.m.
Mom phoned to say that 1hr post vax, pt c/o weakness, dizziness & abd cramps; Advised to see MD; MD office reports that between sx & MMR, pt rod bike a long way in heat & ate lots of junk; thinks sx due to activity rather than MMR;
Injection site selling, 11cm, over the counter ibuprofen taken. Ongoing, >48 hours.  Injection site redness, 15cm, ongoing, 24 hours.
COVID-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced COVID-19 (COVID-19). In February 2022, COVID-19 (COVID-19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. It was reported that the patient took Moderna doses. The patient came down with COVID-19 that put patient seriously down enough evening 2021 until second week of Feb-2022. Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-697987 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-697987:Case for Reporter
The vaccine that was ordered was DTaP-IPV (Quadracel).  The vaccine that was given by mistake was DTaP-Hib-IPV (Pentacel). The patient recieved an exta dose of Hib, and no other symptoms/reactions have been reported by the patient's parents.
One week after receiving the vaccine, my arm began to swell at the injection site. Today it?s larger, about the size of  a tennis ball and it?s warm to the touch. It?s also a little red. It does not hurt.
HA, fatigue, pain at the injection site and nausea. Treatment include: Tylenol, hydration  and tums the next day. Outcome complete resolution of symptoms on day 3.
doses administered after excursion; No adverse event; Patient administered doses of the vaccine after excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 31-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 31-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patient administered doses of the vaccine after excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion).    No Concomitant medications were provided. Reporter reported that a temperature excursion that occurred several days ago in the Freezer.  Multiple patients received vaccine from vaccine that underwent a temperature excursion in the Freezer.  Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine in question. Patient did not report any adverse event.  No treatment medications were provided.
Fever; Nausea; Aches; Arm Pain; This is a spontaneous report from a contactable, consumer. A 59-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch number: EN6200), via an unspecified route of administration in the left arm on 25Feb2021 at 15:00 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient medical history included celiac disease, asthma, HBP- high blood pressure, SVT- Supraventricular tachycardia from an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested negative for COVID-19. Concomitant medications included Bupropion (WELBUTRIN) , oestrogens, conjugated (PREMARIN), furosemide (MANUFACTURER UNKNOWN), ditiazem (MANUFACTURER UNKNOWN), omepraz (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Feb2021 at 06:00, the patient experienced fever, nausea, aches and arm pain. On 12Mar2021, the patient underwent nasal swab test (test name reported as IDnow) and test result showed negative. On 16Mar2021, the patient underwent COVID-19 nasal swab test again and rapid RT-PCR (Reverse transcription polymerase chain reaction) test and both test result showed negative. The patient did not receive any treatment for the events. The clinical outcome of the event fever, nausea, aches and arm pain was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.
IPV vaccine was checked off to give on sheet and placed in Immunization chart by provider(self) during time or physical. Upon review of progress noted at the end of the shift 2/24/2022. Provider identified the IPV vaccine was changed to DTAP-IPV and administered by medical assistant in chart. Provider spoke with medical assistant to determine if vaccine was changed and administered. Medical assistant stated she changed vaccine and gave DTAP-IPV. At this time instructed medical assistant to call parent and notify immediately. Provider called patient twice no answer.
Fever, extreme fatigue, loss of appetite, headache, mental fogginess. I had a concussion / TBI on 2/22/19 in a car accident.  My head, around where I had the concussion from centrifugal force, ached where it had been sore from the accident.  I felt like I had the concussion all over again.  Was in bed for two days with the fever.  Fatigue continued for weeks.
Stomach cramp; sweating; nausea; dizzy weak; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 13:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. The patient did not had any medical history and not had allergies to medications, food, or other products. The patient's concomitant medications were not reported. She did not received any other vaccines within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 13:45, the patient experienced stomach cramp, sweating, nausea and dizzy weak. Therapeutic measures were taken as the result of events was unknown. The clinical outcome of the events stomach cramp, sweating, nausea and dizzy weak was unknown at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Started with sore throat - next overheated then severe chills - temp. 100.6 - eyelids swelled then pus-like and crusting on lashes. Blood pressure 179/108, Pulse 96 (normal is 126/62, 73 Pulse). Very nauseated, muscle pain all over body and at injection site and etc. Gone in 24 hrs, except body aches and eyelids for 4 days.
dizzy; can't eat; temperature of 102.5; nauseous; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), FEEDING DISORDER (can't eat), PYREXIA (temperature of 102.5), NAUSEA (nauseous) and VOMITING (vomiting) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced DIZZINESS (dizzy), FEEDING DISORDER (can't eat), PYREXIA (temperature of 102.5), NAUSEA (nauseous) and VOMITING (vomiting). At the time of the report, DIZZINESS (dizzy), FEEDING DISORDER (can't eat), PYREXIA (temperature of 102.5), NAUSEA (nauseous) and VOMITING (vomiting) outcome was unknown.            Treatment and concomitant medications were not provided by reporter.   This case was linked to MOD-2021-016945 (Patient Link).
Patient received Moderna monovalent as booster dose instead of Moderna bivalent booster.
This spontaneous report received from a physician via a company representative regarding a 11 year old female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date in August 2016 (reported as last month), patient received GARDASIL 9 injection (dose, dose #, route, lot number and expiry date were not reported). On an unknown date in August 2016, the patient had a seizure immediately after receiving an unspecified dose of GARDASIL 9. No treatment was provided for the event. It was not specified how long the seizure had lasted in the patient. The physician recommended her to visit a neurologist due to the seizure. It was unknown if the patient was seen by the neurologist yet. The outcome of seizure was unknown. Causality assessment was not provided by the reporter. Upon internal review, seizure was determined to be medically significant. Additional information has been requested.
This spontaneous report as received from a other health professional (reported as medical assistant and healthcare worker) refers to unspecified number of patients of unknown demographics. No information about medical history concurrent conditions and concomitant medications was reported. It was reported that from an unknown date the ZOSTAVAX was improperly stored for a full year and on an unknown date unspecified number of patients were vaccinated with ZOSTAVAX (dose strength, indication route was not reported). It was unspecified as how many doses were administered to how many patients with this improperly stored ZOSTAVAX. The reporter considered no adverse effect and improperly stored to be not related to ZOSTAVAX. No product quality compliant was involved. This case is linked to the case 1404USA005084. Additional information has been requested.
56 adults patients received doses after its expiration date Jul 13, 2022; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 004m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.   For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (56 adults patients received doses after its expiration date Jul 13, 2022).    No concomitant medications were reported Dose was administered after 30-day Use by Date or after manufacturer date of expiry. Vial did not undergo any temperature excursions.  Treatment information was not provided. This case belongs to patient number 39 out of 56 patients.    This case was linked to US-MODERNATX, INC.-MOD-2023-701125 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-701125:Master case
Swollen and red at the site of the injection and it was itchy and warm; Swollen and red at the site of the injection and it was itchy and warm; Swollen and red at the site of the injection and it was itchy and warm; Swollen and red at the site of the injection and it was itchy and warm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Swollen and red at the site of the injection and it was itchy and warm), INJECTION SITE PRURITUS (Swollen and red at the site of the injection and it was itchy and warm), INJECTION SITE SWELLING (Swollen and red at the site of the injection and it was itchy and warm) and INJECTION SITE ERYTHEMA (Swollen and red at the site of the injection and it was itchy and warm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced INJECTION SITE WARMTH (Swollen and red at the site of the injection and it was itchy and warm), INJECTION SITE PRURITUS (Swollen and red at the site of the injection and it was itchy and warm), INJECTION SITE SWELLING (Swollen and red at the site of the injection and it was itchy and warm) and INJECTION SITE ERYTHEMA (Swollen and red at the site of the injection and it was itchy and warm). The patient was treated with PENICILLIN NOS (PENICILLIN [PENICILLIN NOS]) for Adverse event NOS, at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (Swollen and red at the site of the injection and it was itchy and warm), INJECTION SITE PRURITUS (Swollen and red at the site of the injection and it was itchy and warm), INJECTION SITE SWELLING (Swollen and red at the site of the injection and it was itchy and warm) and INJECTION SITE ERYTHEMA (Swollen and red at the site of the injection and it was itchy and warm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Extreme chills & fatigue Consistent 103* fever over 24 hours, despite  Tylenol, 1000mg, 4x/day lack of appetite
golf ball size lump - happened 24 hours after and now 48 hours after has gone down
Patient received vaccination at 10:15am, waited 15 minutes, then went to work. Patient reported blurry vision, cold chills, dizziness and stomach cramping beginning  12:30pm. Patient sat down and began experiencing a new onset headache.  Patient tried to get up once, sat down, then tried to get up again and reportedly blacked out.  Patient was aroused by coworkers at which time was taken to his residence. Patient did not seek treatment. Roughly 24 hours after the event the patient reported still feeling weak and light headed.  Patient was urged to seek medical treatment.
Family noted right arm swollen and red 48 hrs after vaccine. Child not bothered by arm. Right upper arm erythema, swollen, mildly warm to touch. Right upper arm diameter 20cm vs 17 1/2 cm left arm.